Switching Maintenance Infliximab Therapy to Biosimilar-Infliximab Does Not Lead to Significant Changes in Health-Related Quality of Life and Clinical Outcomes in Inflammatory Bowel Disease Patients

Value in Health - United Kingdom
doi 10.1016/j.jval.2017.08.833
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pregnancy Outcomes in Women With Inflammatory Bowel Disease Treated With Biosimilar Infliximab

Gastroenterologie a Hepatologie
HepatologyGastroenterology
2018English

Letter: Is There a Role for Infliximab Biosimilar in Patients With Inflammatory Bowel Disease With Secondary Loss of Response to Infliximab Innovator?

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Efficacious Transition From Reference Infliximab to Biosimilar Infliximab in Clinical Practice

International Journal of Rheumatic Diseases
Rheumatology
2019English

Timing of Last Preoperative Dose of Infliximab Does Not Increase Postoperative Complications in Inflammatory Bowel Disease Patients

Digestive Diseases and Sciences
PhysiologyGastroenterology
2016English

Does Infliximab Increase Complications After Surgery for Inflammatory Bowel Disease?

F1000 Medicine Reports
2009English

Health-Related Quality of Life of Patients With Inflammatory Bowel Disease in Singapore

Intestinal Research
Gastroenterology
2019English

Letter: Infliximab Therapy for Patients With Inflammatory Bowel Disease - Some Unanswered Questions. Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2015English

Assessing Health-Related Quality of Life in Patients With Inflammatory Bowel Disease, in Crete, Greece

BMC Gastroenterology
MedicineGastroenterology
2002English

Efficacy of Adalimumab in Patients With Crohn's Disease and Failure to Infliximab Therapy: A Clinical Series

Revista Espanola de Enfermedades Digestivas
MedicineGastroenterology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy